Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.



Mother of Teen Church-Goer Who Died in Crash Files Lawsuit

Attorney Joseph Fried has filed a negligence lawsuit against truck driver Steve Holland and others on behalf of the mother of 14-year-old Jeremiah Warren, Chasity Warren. Court documents show Holland received numerous tickets between 2000 and 2014 for violations such as speeding, driving an unsafe vehicle, and driving an overloaded vehicle. 


Popular Jewelry Company Settles CFPB Lawsuit

The U.S. Consumer Financial Protection Bureau (CFPB) and New York’s attorney general, Letitia James, filed a lawsuit against Sterling Jewelers Inc, accusing the wholly owned jewelry subsidiary of Signet Jewelers Ltd, of improper credit financing practices.  Sterling was accused of submitting credit applications and causing credit cards to be issued without the knowledge or consent



Building a Wall Will Not Solve the Opioid Problem

The Food and Drug Administration (FDA), Congress, and the White House have long faced significant obstacles regulating pharmaceutical drugs. Because of this, policymakers are reluctant to regulate legal drugs and primarily target the illegal drug market instead.